GENE - Dead pump bouncing, potential buy although ideally wait for more spiking to get short.
REFR - Lincoln just announced they're using REFR's electronic dimming glass tech on their new Continental concept that due to be released next year. This is big news for REFR as Lincoln mentioned the tech in their own PR, potential buy.
GMAN is up on earnings yet earnings is going down each year with
this year being down significantly. Co has 7M cash and 41M in debt.
Technically the chart has a tonne of overhead resistance, potential short
GBSN is a 14M company and recent IPO. Stock up on a video
conference, transcript basically read like a hyped up PR with tonnes of
forward looking statement. Co admitted their stock "awareness" is of
high priority and also did a financing on the 6th of March. Stock is also being pumped by a number of newsletters/Twitter Furus. Price action and volume was snooze worthy yesterday, still a potential short.
ORMP is a paid pump by http://tickerresearch.com. Potential short ideally once 6 cracks.
ADXS, CORT are biotech stocks spiking. ADXS is stuck in a channel
between 12 & 14. Both are potential short. If ADXS can break 14.5
it's a potential b/o buy as shorts are likely to get squeezed.
No comments:
Post a Comment